AbbVie (ABBV) Income towards Parent Company (2012 - 2026)
AbbVie (ABBV) reported Income towards Parent Company of $3.61 billion for Q2 2026, up 285.2% from $938 million a year earlier and up 419.9% from the prior quarter.
AbbVie (ABBV) Income towards Parent Company (2012 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, AbbVie's Income towards Parent Company came in at $6.31 billion, up 67.7% year-over-year; for FY2025, it came in at $4.23 billion, down 1.2% from FY2024.
- Income towards Parent Company has declined for three consecutive years, with a five-year compound annual growth rate of -1.7% (FY2020 to FY2025).
- By year, Income towards Parent Company came in at $4.28 billion in FY2024 (-12.0%), $4.86 billion in FY2023 (-58.9%), $11.84 billion in FY2022 (+2.5%) and $11.54 billion in FY2021 (+150.0%).
- The Q2 2026 figure ranks as the highest quarterly Income towards Parent Company since Q3 2022.
- Year over year, Income towards Parent Company gained in 1 of the last six quarters, with growth averaging 16.9%.
- The high point for year-over-year Income towards Parent Company in five years was Q1 2024 (growth of 472.8%); the low point was Q1 2023 (a decline of 94.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $695 million (Q1 2026), $1.82 billion (Q4 2025) and $186 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn |
| 10 | Vertex Pharmaceuticals | 126.70 Bn | 98.70 Bn | 2.84 Bn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.61 Bn |
| Mar 31, 2026 | 695.00 Mn |
| Dec 31, 2025 | 1.82 Bn |
| Sep 30, 2025 | 186.00 Mn |
| Jun 30, 2025 | 938.00 Mn |
| Mar 31, 2025 | 1.29 Bn |
| Dec 31, 2024 | -22.00 Mn |
| Sep 30, 2024 | 1.56 Bn |
| Jun 30, 2024 | 1.37 Bn |
| Mar 31, 2024 | 1.37 Bn |
| Dec 31, 2023 | 822.00 Mn |
| Sep 30, 2023 | 1.78 Bn |
| Jun 30, 2023 | 2.02 Bn |
| Mar 31, 2023 | 239.00 Mn |
| Dec 31, 2022 | 2.47 Bn |
| Sep 30, 2022 | 3.95 Bn |
| Jun 30, 2022 | 924.00 Mn |
| Mar 31, 2022 | 4.49 Bn |
| Dec 31, 2021 | 4.04 Bn |
| Sep 30, 2021 | 3.18 Bn |
AbbVie Income towards Parent Company API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=ABBV&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-towards-parent-company", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();